Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.

BACK TO LIST

Patient
Name:	Cantón, , Urbano,
DOB:	01-APR-1945 (Age: 80)
Gender:	male
Address:	Vial Vito Trujillo 29 Piso 2 38001 Santa Cruz de Tenerife (Spain)
ID:	8854-480268-4 (ECI)

Report
Date:	28-MAR-2023

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Centro de Salud Ruiz de Padrón (Spain)

Specimen
Collected:	28-MAR-2023

Chemistry

Test	28-MAR-2023	Reference Range	Unit
Hemoglobin A1c/Hemoglobin.total in Blood	5.4	4.5 - 6.4	%
Glucose [Mass/volume] in Blood	85.3	70 - 140	mg/dL
Urea nitrogen [Mass/volume] in Blood	11.5	7 - 25	mg/dL
Creatinine [Mass/volume] in Blood	0.6 L	0.9 - 1.3	mg/dL
Calcium [Mass/volume] in Blood	8.8	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	139.0	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	5.0	3.5 - 5.1	mmol/L
Chloride [Moles/volume] in Blood	104.3	98 - 110	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	26.8	22 - 29	mmol/L
Cholesterol [Mass/volume] in Serum or Plasma	249.0 H	100 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	100.5	45 - 175	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	169.1	0 - 190	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	59.7	40 - 100	mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine	11.0	0 - 30	mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
Laboratory results are largely within normal limits. Notable findings include mildly decreased creatinine, likely reflecting low muscle mass rather than renal dysfunction in this elderly patient, and elevated total cholesterol, which may increase cardiovascular risk. Glucose control and renal markers are unremarkable. No evidence of significant proteinuria. Recommend clinical correlation and consideration of lipid management if appropriate.

Conclusion and Recommendations based on this report and previous findings known to us

Laboratory results are largely within normal limits. Notable findings include mildly decreased creatinine, likely reflecting low muscle mass rather than renal dysfunction in this elderly patient, and elevated total cholesterol, which may increase cardiovascular risk. Glucose control and renal markers are unremarkable. No evidence of significant proteinuria. Recommend clinical correlation and consideration of lipid management if appropriate.